Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HBW 023

Known as: HBW-023 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
ObjectiveTo define an optimal dose of hirudin that would improve early coronary artery Thrombolysis in Myocardial Infarction… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The aim of this multicentre, prospective, randomised, dose-ranging study was to compare the safety and efficacy of subcutaneous… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
OBJECTIVES This study was performed to evaluate the efficacy of peri-interventional treatment with recombinant hirudin (r-hirudin… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Heparin‐induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or… Expand
Is this relevant?
1995
1995
In a double-blind, randomized, crossover study, we investigated in 15 healthy male volunteers the effects of recombinant (r… Expand
Is this relevant?
1995
1995
To evaluate the efficacy and safety of hirudin, a direct thrombin inhibitor, in patients with acute myocardial infarction, a dose… Expand
Is this relevant?
1994
1994
BACKGROUND Recombinant hirudin, a pure, specific antithrombin could be more effective than heparin in the treatment of deep vein… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The first experience with hirudin as an alternative anticoagulant for heparin in hemodialysis is reported. Recombinant hirudin… Expand
Is this relevant?
1993
1993
: Recombinant Hirudin (rH) is an anticoagulant agent with a specific antithrombin activity independent of antithrombin III. We… Expand
Is this relevant?
1993
1993
Recombinant Hirudin (rH) is an anticoagulant agent with a specific antithrombin activity independent of antithrombin III. We… Expand
Is this relevant?